Loading…
Based on limited metadata, this FDA Warning Letter was issued to EPH Technologies, Inc. on November 18, 2019, regarding drug products. Without access to the full letter text or detailed subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulatory oversight, though the specific issuing office is not documented in the metadata provided. Additional review of the complete warning letter would be necessary to identify the particular compliance issues cited.